Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S Post author: Post published: February 13, 2024 Post category:uncategorized The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants. You Might Also Like Study reveals links between bodily rhythms and visual perception September 19, 2024 Functional, nonepileptic seizures linked to higher death rate than expected January 24, 2024 Breakthrough technique enables clear visualization of organs in the body September 8, 2024